The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Bioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8 + T Cell Exhaustion
Open accessAbstract
Dynamic reprogramming of metabolism is essential for T cell effector function and memory formation. However, the regulation of metabolism in exhausted CD8(+) T (Tex) cells is poorly understood. We found that during the first week of chronic lymphocytic choriomeningitis virus (LCMV) infection, before severe dysfunction develops, virus-specific CD8(+) T cells were already unable to match the bioenergetics of effector T cells generated during acute infection. Suppression of T cell bioenergetics involved restricted glucose uptake and use, despite persisting mechanistic target of rapamycin (mTOR) signaling and upregulation of many anabolic pathways. PD-1 regulated early glycolytic and mitochondrial alterations and repressed transcriptional coactivator PGC-1α. Improving bioenergetics by overexpression of PGC-1α enhanced function in developing Tex cells. Therapeutic reinvigoration by anti-PD-L1 reprogrammed metabolism in a subset of Tex cells. These data highlight a key metabolic control event early in exhaustion and suggest that manipulating glycolytic and mitochondrial metabolism might enhance checkpoint blockade outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Repression of PGC1α, an important cofactor of NRF1 activity, is an early event in T cell exhaustion, indicating a mechanistic overlap between T cell aging and exhaustion”
From Successful and Maladaptive T Cell Aging (2017) · cites this paper as Bengsch et al., 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Okoye, I., Wang, L., Pallmer, K., Richter, K., Ichimura, T., Haas, R., Crouse, J., Choi, O., Heathcote, D. A., Lovo, E., et al. (2015) · Science · doi:10.1126/science.aaa7516 · Cited by 51 · cited 1×
“In support of this notion, improving mitochondrial OXPHOS by overexpression or gain-of-function of lymphocyte expansion molecule (lem) increased virus-specific T cell function and viral control early during clone 13 infection (Okoye et al., 2015).”
BackgroundRetractedSubramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625 · cited 1×
“GSEA used gene sets from the Molecular Signature Database v.5.0 (Subramanian et al., 2005) including KEGG pathway gene lists obtained from http://www.genome.jp/kegg/pathway.html.”
MethodInfluentialMolecular and cellular insights into T cell exhaustion
Wherry, E. J., & Kurachi, M. (2015) · Nature Reviews Immunology · doi:10.1038/nri3862 · Cited by 4,652 · cited 3×
“Tex cells are defined by poor effector functions, high co-expression of multiple inhibitor receptors and an altered global transcriptional program compared to functional Teff or Tmem cells (Wherry and Kurachi, 2015).”
BackgroundSelf-citationRestoring function in exhausted CD8 T cells during chronic viral infection
Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2005) · Nature · doi:10.1038/nature04444 · Cited by 4,057 · cited 1×
“PD-L1 blockade resulted in an expansion of virusspecific T cells associated with lower viral load (data not shown), as previously described (Barber et al., 2006).”
ResultSelf-citationPosttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis
Chang, C.-H., Curtis, J. D., Maggi, L. B., Faubert, B., Villarino, A. V., O’Sullivan, D., Huang, S. C.-C., van der Windt, G. J. W., Blagih, J., Qiu, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.05.016 · Cited by 2,204 · cited 3×
“In addition, switching to glycolysis is directly linked to increased effector function (Chang et al., 2013; Ho et al., 2015).”
BackgroundResultMolecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection
Wherry, E. J., Ha, S.-J., Kaech, S. M., Haining, W. N., Sarkar, S., Kalia, V., Subramaniam, S., Blattman, J. N., Barber, D. L., & Ahmed, R. (2007) · Immunity · doi:10.1016/j.immuni.2007.09.006 · Cited by 2,103 · cited 3×
“Differences between in vitro studies and the current data might be due to differences between in vitro activated Teff-like cells and in vivo generated Tex cells that are transcriptionally and phenotypically distinct from Teff cells (Doering et al., 2012; Wherry et al., 2007).”
BackgroundResultSelf-citationCheckpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
Gubin, M. M., Zhang, X., Schuster, H., Caron, E., Ward, J. P., Noguchi, T., Ivanova, Y., Hundal, J., Arthur, C. D., Krebber, W.-J., et al. (2014) · Nature · doi:10.1038/nature13988 · Cited by 1,974 · cited 2×
“PD-1 blockade in tumor models is associated with transcriptional changes in metabolic genes (Gubin et al., 2014).”
BackgroundCTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms
Parry, R. V., Chemnitz, J. M., Frauwirth, K. A., Lanfranco, A. R., Braunstein, I., Kobayashi, S. V., Linsley, P. S., Thompson, C. B., & Riley, J. L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9543-9553.2005 · Cited by 1,931 · cited 1×
“The intracellular tail of PD-1 contains an immunotyrosine inhibitorymotif (ITIM) and an immunotyrosine switchmotif (ITSM), that can recruit phosphatases such as SHP-2, allowing dephosphorylation of key signal transducers (Chemnitz et al., 2004; Okazaki et al., 2001).”
BackgroundmTOR regulates memory CD8 T-cell differentiation
Araki, K., Turner, A. P., Shaffer, V. O., Gangappa, S., Keller, S. A., Bachmann, M. F., Larsen, C. P., & Ahmed, R. (2009) · Nature · doi:10.1038/nature08155 · Cited by 1,575 · cited 3×
“This treatmentmildly reduced the number of virus-specific T cells (Figures 4B and 4C) as expected based on the role of mTOR in effector CD8+ T cell expansion (Araki et al., 2009; Pearce et al., 2009).”
BackgroundEnhancing CD8 T-cell memory by modulating fatty acid metabolism
Pearce, E. L., Walsh, M. C., Cejas, P. J., Harms, G. M., Shen, H., Wang, L.-S., Jones, R. G., & Choi, Y. (2009) · Nature · doi:10.1038/nature08097 · Cited by 1,559 · cited 1×
“This treatmentmildly reduced the number of virus-specific T cells (Figures 4B and 4C) as expected based on the role of mTOR in effector CD8+ T cell expansion (Araki et al., 2009; Pearce et al., 2009).”
Background
Flagged first, then by citations
Cited by
Sorted by citations
Items 701–800 of 867
Atilla, E. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1863485 · Cited by 1
Circadian rhythm, oxidative stress, and cancer immunosuppression
Li, Y., Nepovimová, E., Wu, Q., & Kuča, K. (2026) · Archives of Toxicology · doi:10.1007/s00204-026-04500-1 · Cited by 1
“Importantly, N-AC treatment restores TCF-1 expression and improves tumor cell killing capacity, even in models resistant to anti-PD-L1 therapy (Bengsch et al. 2016; Vardhana et al. 2020).”
Mitochondrial Energy Metabolism in Cancer, Immunoregulation and Antitumour Response
Patrício, J. S., Mendes, C., & Gameiro, P. A. (2026) · Advances in experimental medicine and biology · doi:10.1007/978-3-032-12166-0_17 · Cited by 1
Omene, E. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1849888 · Cited by 1
Lin, H., Chen, Y., & Chu, P. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118269 · Cited by 1
Metabolic aspects of adoptive immunotherapy of tumors
Kazanskiy, D. B., Silaeva, Y. Y., Kalinina, A. A., Zamkova, M. A., Khromykh, L. M., Александровна, П. Н., & Dzholokhava, L. K. (2017) · Advances in molecular oncology · doi:10.17650/2313-805x-2017-4-3-21-26 · Cited by 1
Delivery strategies for ex vivo and in vivo T-cell reprogramming
Ben‐Akiva, E., Karlsson, J. E., Tzeng, S. Y., Yu, H., & Green, J. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85781-9.00002-6 · Cited by 1
The Tox Gene Encodes Two Proteins with Distinct and Shared Roles in Gene Regulation
Yeckes, A. R., Victor, A. R., Zhu, Z., Narayanan, M., Srinivasan, B., Bruce, B., & Kaye, J. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200659 · Cited by 1
Hong, A. N., Zhe, S. H. I., Fu, B., Yao, X., Ni, H., Yong, G. U. O., Xiao, L., & Wang, X. (2021) · The Thai Journal of Veterinary Medicine · doi:10.56808/2985-1130.3148 · Cited by 1
Wei, Z., Liu, C., Liang, J., Zhou, X., Xue, K., Wang, K., & Zhang, X. (2024) · IUBMB Life · doi:10.1002/iub.2818 · Cited by 1
Wilson, H., MacDonald, D. C., & Bryce, K. (2024) · Case Reports in Gastroenterology · doi:10.1159/000539646 · Cited by 2
T-Cell Metabolism and Its Dysfunction Induced by Cancer
Prado-Garcı́a, H., Sandoval-Martinez, R., & Romero‐Garcia, S. (2020) · Springer eBooks · doi:10.1007/978-3-030-30845-2_7 · Cited by 1
Harnessing metabolism for reinvigorating dysfunctional T cells in cancer
Romero‐Garcia, S., Castro‐Flores, D. A., & Prado-García, H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822028-3.00005-4 · Cited by 1
Immune Mechanisms of Viral Clearance and Disease Pathogenesis During Viral Hepatitis
Ferrari, C. I., & Mondelli, M. U. (2009) · Wiley eBooks · doi:10.1002/9780470747919.ch51 · Cited by 1
The 2018 American Academy of Allergy, Asthma & Immunology Foundation Faculty Development awardees
Ballas, Z. K. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.05.023 · Cited by 1
Lepez, A., Pirnay, T., Denanglaire, S., Pérez-Morga, D. L., Vermeersch, M., Léo, O., & Andris, F. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.06.978791 · Cited by 1
Siska, P. J., Singer, K., Klitzke, J., Kauer, N., Decking, S.-M., Bruß, C., Matos, C., Kolodová, K., Peuker, A., Schoenhammer, G., et al. (2020) · medRxiv · doi:10.1101/2020.09.18.20194175 · Cited by 1
Calvet‐Mirabent, M., Sánchez‐Cerrillo, I., Martin-Cofreces, N. B., de la Fuente, H., Tsukalov, I., Delgado‐Arévalo, C., Calzada, M. J., Santos, I. D. L., Sanz, J., García-Fraile, L. J., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.14.476403 · Cited by 1
“5 [23-70], 64% males) were provided either by the Immunology Service from Hospital de La Princesa or Centro de Transfusión of Comunidad de Madrid, Spain (Table 2) and used for comparison purposes.”
MethodThe coenzyme A precursor pantethine restrains sarcoma growth through promotion of type 1 immunityPreprint
MIALLOT, R., Millet, V., Roger, A., Fenouil, R., Tardivel, C., Martin, J., Shintu, L., BERCHARD, P., Lanza, J. S., MALISSEN, B., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-2345803/v1 · Cited by 1
Editorial: T cell exhaustion; mechanisms of induction, modulation, and recovery
Abdel-Hakeem, M. S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1122530 · Cited by 2
“Another important aspect of TEX deviation from the acute differentiation path is adopting a different metabolic lifestyle (19), which was confirmed in consequent studies (20, 21).”
BackgroundAkiso, M., Ameka, M., Naidoo, K. K., Langat, R., Kombo, J., Sikuku, D., Ndung’u, T., Altfeld, M. A., Anzala, O. A., & Mureithi, M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.17.541113 · Cited by 1
“Additionally, our study did not measure T-cell exhaustion, but previous results suggest that a similarly distorted metabolic phenotype is an upstream indicator of T-cell exhaustion(21).”
BackgroundResultInfluentialA PD-1-ST2 axis controls Th2 effector function in tissue via a metabolic checkpointPreprint
Heieis, G. A., Everts, B., Roberts, C. W., Maizels, R. M., & Perona‐Wright, G. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.13.553117 · Cited by 1
Mancebo-Pérez, C., Benítez-Martínez, A., Tsukalov, I., Grau-Expósito, J., Castellví, J., Mañalich, L., Centeno, C., Planas, B., Navarro, J., Burgos, J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.09.647906 · Cited by 1
Studies of innate and adaptive lymphocytes in human liver diseases and viral infections
Zimmer, C. L. (2019) · Figshare
Advancing transcriptome analysis in models of disease and ageing
de Jong, T. V. (2019) · doi:10.33612/diss.99203371
Heeran, A. B. (2021) · Arrow@dit (Dublin Institute of Technology)
NK cell-mediated immunotherapy: The exquisite role of PGC-1a in metabolic reprogramming
Gerbec, Z. J., & Malarkannan, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-824375-6.00006-0
Targeting metabolism to potentiate NK cell-based therapies
Dhar, P., & Wu, J. D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-824375-6.00016-3
Zhang, L., Guo, Y., & Nishi, H. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.05.451111
Spatiotemporal Co-Dependency between Macrophages and Exhausted CD8 + T Cells in CancerPreprint
Kersten, K., Hu, K. H., Combes, A. J., Samad, B., Harwin, T., Ray, A., Rao, A. A., Cai, E., Marchuk, K., Artichoker, J., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3942126
Metabolic Profile of Adaptive Immune Cells
Domínguez-Amorocho, O. A., Soto‐Heredero, G., & Mittelbrunn, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-86684-6_6
Hope, J. L., Otero, D. C., Bae, E., Stairiker, C. J., Palete, A. B., Faso, H. A., Henriquez, M. L., Seo, H., Lei, X., Wang, E. S., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.24.477602
“Early during the development of T cell exhaustion, CD8 + T cells demonstrate reduced respiration (OCR) and glycolysis 27 .”
BackgroundWoodland, D. L. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735141981.793557277
Tsokos, G. C. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727394204.793570386
Chemoenzymatic Measurement of Cell-surface Glycan in Single-cell Multiomics: LacNAc as an ExamplePreprint
Yu, W., Zhao, X., Jalloh, A. S., Zhao, Y., Dinner, B., Yang, Y., Ouyang, S., Li, Y., Tian, T., Zhao, Z., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.01.506123
HDAC7 controls anti-viral and anti-tumor immunity by CD8 + T cellsPreprint
Yerinde, C., Keye, J., Durlanik, S., Freise, I., Nowak, F., Hsiao, H.-J., Letizia, M., Schlickeiser, S., Obermayer, B., Huck, A., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.18.508452
Assessment of the Mitochondrial Condition in CD4+ and CD8+ T-Lymphocytes from Healthy Subjects
Korolevskaya, L. B., Сайдакова, Е. В., Геннадьевна, Ш. Н., & Владимирович, Ш. К. (2022) · Cell and Tissue Biology · doi:10.1134/s1990519x22050054
“It is known that, in pathological situations, CD8+ T-lymphocytes are more prone to exhaustion than CD4+ T-lymphocytes (Bengsch et al., 2016; McLane et al., 2019; Yu et al., 2020).”
BackgroundPassos‐Castilho, A. M., Udhesister, S. T. P., Fontaine, G., Jeong, D., Dickie, M., Lund, C., Russell, R. S., & Kronfli, N. (2022) · Canadian Liver Journal · doi:10.3138/canlivj-2022-0034
Nanotechnology to Correct Mitochondrial Disorders in Cancer Diseases
Faria, R., Albuquerque, T., Neves, A. R., Sousa, Â., & Costa, D. R. B. (2022) · Springer eBooks · doi:10.1007/978-3-031-17831-3_6
The Prospects of Immunotherapy in Pancreatic Cancer
Ying, H., & Yao, W. (2022) · Springer eBooks · doi:10.1007/978-3-031-05724-3_22
van Pul, L., Stunnenberg, M., Boeser‐Nunnink, B., Harskamp, A. M., Geijtenbeek, T. B. H., & Kootstra, N. A. (2023) · Research Square · doi:10.21203/rs.3.rs-2408098/v1
T-Cell Metabolism and Its Regulation by Checkpoint Molecules: Consequences for Cancer Immunotherapy
Romero‐Garcia, S., Mendoza, M. S., Carlos‐Reyes, Á., & Prado-Garcı́a, H. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_159-1
Liu, J., He, M., Liu, Y., Liu, M., Wang, H., Gu, W., Gao, Y., Li, Z., & Song, H. (2023) · Research Square · doi:10.21203/rs.3.rs-2691058/v1
Wu, H., Zhao, X., Hochrein, S. M., Eckstein, M., Gubert, G. F., Knöpper, K., Mansilla, A. M., Öner, A., Doucet-Ladevèze, R., Schmitz, W., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.31.555662
Giuliani, G., Stewart, W., Li, Z., Jayaprakash, C., & Das, J. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.06.570410
Mai, L. T., Swaminathan, S., Nguyen, T. H., Charpentier, T., Loucif, H., Carmona‐Pérez, L., Lamarre, A., Heinonen, K. M., Fritz, J. H., & Stäger, S. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.29.577789
Role of Kupffer cells and other immune cells
Puengel, T., & Tacke, F. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95262-0.00024-3
YTHDF2 upregulation and relocation dictate CD8 T cell polyfunctionality in tumor immunityPreprint
Zhang, H., Luo, X.-J., Yang, W., Wu, Z., Zhao, Z., Pei, X., Zhang, X., Chen, C., Lei, J. H., Shi, Q., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.11.603088
Targeting Mitochondria in Cancer Immunotherapy: Promises and Pitfalls
Allami, P., Mortaheb, S., Aghakhani, A., & Rezaei, N. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_448
The role of cellular persistence in CAR T cell therapy
Menkhoff, V. D., Bernhard, S., Michaelides, S., Stock, S., & Kobold, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-14064-8.00029-1
Ponzo, M., Drufuca, L., Buracchi, C., Sindoni, M. M., Nucera, S., Bugarin, C., Bason, R., Rossetti, G., Bonnal, R. J. P., Meli, C., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.20.629119
Ramos, A., Simon, S., Siller‐Farfán, J. A., Rajan, A., Revale, S., di Castiglionchio, E. Z., Pelea, O., Fulga, T. A., Riddell, S. R., Dushek, O., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.10.637482
Immuno-cell metabolic changes in HIV-1 infection
Li, X., Jiang, Y., Zheng, X., & Shi, H. (2025) · Infectious Diseases & Immunity · doi:10.1097/id9.0000000000000159 · Cited by 1
Lack of Bcl6 promotes anti-tumor immunity by activating glycolysis to rescue CD8 T cell functionPreprint
Luan, F., Li, Y., Ning, J., Tran, J. T., Blane, T. R., Bhargava, R., Huang, Z., Xiao, C., & Nemazee, D. A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.01.646721
MacLean, F., Zemek, R. M., Tsegaye, A. T., Graham, J. B., Swarts, J. L., Vick, S. C., Potchen, N. B., Talavera, I. C., Warrier, L., Dubrulle, J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.24.661157
Cellular Metabolism Controls Lymphocyte Activation and Differentiation
Powell, J. D., & Sun, I. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00180-0
Immunometabolism Governs T Cell Immunity
Raynor, J. L., Shi, H., & Chi, H. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00275-1
Li, H., Yang, S., Zhao, H., Zhang, J., Guo, W., Shen, T., & Han, Q. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178108
Li, S., Wang, H., Wang, P., Yang, T., Li, J., Liu, M., Fu, Y., Jiang, Y., Zhang, Z.-N., & Shang, H. (2025) · mBio · doi:10.1128/mbio.01702-25
“The MMP supports ATP production during oxidative phosphorylation, and a lower membrane potential may cause impairment of T cell mitochondrial function, increasing the level of depolarized mitochondria (38, 39), and mitochondrial damage plays a critical role in pyroptosis (26).”
Tomoda, T., Kawana‐Tachikawa, A., Shimizu, S., Takahashi, S., Kanegane, H., Kamiya, T., Inoue, K., Takagi, M., & Morio, T. (2025) · Research Square · doi:10.21203/rs.3.rs-7518621/v1
Progenitor T cells drive chronic pulmonary type 2 inflammation
Kratchmarov, R., Jia, X., Nagai, J., Pacheco, G. A., Perniss, A., Bell, M. A., Gül, E., Thompson, T. W., Hayashi, H., Saghaei, S., et al. (2026) · Nature Immunology · doi:10.1038/s41590-026-02619-y
“These results suggest the presence of divergent underlying metabolic programs, of note given the bioenergetic insufficiency seen in chronic infection 78 and role of catabolism in self-renewal 79 .”
T-Cell Metabolism and Its Regulation by Checkpoint Molecules: Consequences for Cancer Immunotherapy
Romero‐Garcia, S., Mendoza, M. S., Carlos‐Reyes, Á., & Prado-Garcı́a, H. (2025) · Springer eBooks · doi:10.1007/978-3-032-00765-0_159
Schlaak, A. E., Thimme, R., & Bengsch, B. (2025) · Die Onkologie · doi:10.1007/s00761-025-01854-6
Self-citationTranslational Downregulation of 5’ TOP mRNAs During T Cell ExhaustionPreprint
Pledger, E. S., Ambavaram, N., Ferguson, L., & Cate, J. H. D. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.15.694525
Huang, M., Yu, X., Wang, Q., Jiang, Z., Li, X., Chen, W., & 宋传贵 (2024) · Figshare · doi:10.6084/m9.figshare.24993741
Zhang, Y., Hu, H.-H., Zhou, S.-H., Xia, W., Zhang, Y., Zhang, J.-P., Fu, X.-L., & Yu, W. (2023) · Figshare · doi:10.6084/m9.figshare.22600454
Sun, G., Liu, C., Lu, Z., Zhang, J., Cao, H., Huang, T., Dai, M., Liu, H., Feng, T., Tang, W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25951969
Zhang, Y., Hu, H.-H., Zhou, S.-H., Xia, W., Zhang, Y., Zhang, J.-P., Fu, X.-L., & Yu, W. (2023) · Figshare · doi:10.6084/m9.figshare.22600457
Zhang, Y., Hu, H.-H., Zhou, S.-H., Xia, W., Zhang, Y., Zhang, J.-P., Fu, X.-L., & Yu, W. (2023) · Figshare · doi:10.6084/m9.figshare.22600451
Sun, G., Liu, C., Lu, Z., Zhang, J., Cao, H., Huang, T., Dai, M., Liu, H., Feng, T., Tang, W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25951885
Wu, K., Han, N., Mao, Y., & Li, Y. (2023) · Figshare · doi:10.6084/m9.figshare.23292132
Zhang, Y., Hu, H.-H., Zhou, S.-H., Xia, W., Zhang, Y., Zhang, J.-P., Fu, X.-L., & Yu, W. (2023) · Figshare · doi:10.6084/m9.figshare.22600460
Zhang, Y., Hu, H.-H., Zhou, S.-H., Xia, W., Zhang, Y., Zhang, J.-P., Fu, X.-L., & Yu, W. (2023) · Figshare · doi:10.6084/m9.figshare.22600448
Zeng, D., Hu, Z., Yi, Y., Valeria, B., Shan, G., Chen, Z., Zhan, C., Lin, M., Lin, Z., & Wang, Q. (2021) · Figshare · doi:10.6084/m9.figshare.16786906
Zhukova, М. А., Ermakova, N. N., Pan, E. S., & Skurikhin, Е. G. (2026) · Biomedicines · doi:10.3390/biomedicines14010112
Mitochondrial metabolic remodeling predicts therapeutic response to PegIFN-α in chronic hepatitis B
Zhang, Y., Han, X., Xu, C., Song, Y., Zhu, J., Zhou, R., Chen, Y., Liu, M., Xu, J., Wu, X., et al. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1719456
Transcriptional and Epigenetic Regulation of T Cell States in Cancer
Ma, S., Hargreaves, D. C., & Kaech, S. M. (2026) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-061325-042744
Li, Y., He, L., Li, P., Chen, R., Li, F., Yang, L., Zhou, Y., Zhang, Z., Liu, S., Zhao, J., et al. (2026) · Veterinary Microbiology · doi:10.1016/j.vetmic.2026.110950
Dual roles of immunosenescence in cancer immunotherapy
Yu, Y., Sun, L., & Fan, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1779141
Viscoelasticity reprograms T cell metabolism for TCR-T cell manufacturing and therapyPreprint
Li, S., Yang, Y., Li, Y.-R., Liu, Z., Zhou, H., Zhu, Y., Shen, X., Lai, D., Cen, Y., Miller, E., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-8855735/v1
Sengupta, S., & Chatterjee, M. (2026) · Parasite Immunology · doi:10.1111/pim.70069
Metabolic Constraints and Interactions Drive T-cell Function and Exhaustion in Cancer Progression
Tzeng, S., & Tsai, C.-H. (2026) · Journal of Medical Sciences · doi:10.4103/jmedsci.jmedsci_234_25
Li, S., Shiekh, P. A., Li, Y.-R., Nan, H., Yang, L., Mitchell, K., Yang, Y., & Zhu, Y. (2026) · Research Square · doi:10.21203/rs.3.rs-8296891/v1
Mitochondria and resistance to immunotherapy
Adhikary, K., Chakraborty, A., Chatterjee, S., Ganguly, K., & Maiti, R. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40535-8.00008-9
Translating IL-2/anti-IL-2 antibody complexes treatment for human tumor immunotherapy
Caudana, P. (2018) · theses.fr (ABES) · doi:10.70675/8a93b17bz416az4e49z9a3bz92c1c8a4cf8c
Rôle de la Neuropiline-1 dans les fonctions effectrices des lymphocytes T CD8 antitumoraux
Leclerc, M. (2018) · theses.fr (ABES) · doi:10.70675/13aee211zad7bz4b07z9a5fz29b15750d99c
Pharmacologic DPP-4 inhibition promotes CD8⁺ T cell metabolic fitness to enhance anti-tumor activityPreprint
Pumar, O. T., VanNoy, E. L., Haffey, A., Gannamedi, D. P., Rafie, C. I., Harwood, D. S. L., Benedetti, J. R., Ballard, C. A. P., Ciervo, E., Coroa, P. H. A. T., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.31.715681
Self-citationDéfauts fonctionnels des cellules NK en contexte de stimulation chronique
Marotel, M. (2019) · theses.fr (ABES) · doi:10.70675/1dcb97a5za482z4664zaaf6z62a53817eea9
Role of co-activating receptors CD226 and CD137 in T cell exhaustion
Pichler, A. (2020) · theses.fr (ABES) · doi:10.70675/ec9fb2bazf7a9z4305z9a58zb5cbc6e74e63
The anti-tumoral effects of a low protein diet and of the IRE1α signaling
Turtos, A. M. (2022) · theses.fr (ABES) · doi:10.70675/fd90a3e8ze35az42fdzbd0ez966f12ddad22
Metadata
- Authors
- Bengsch, B., Johnson, A. L., Kurachi, M., Odorizzi, P. M., Pauken, K. E., Attanasio, J., Stelekati, E., McLane, L. M., Paley, M. A., Delgoffe, G. M., & Wherry, E. J.
- Affiliations
- University of Pennsylvania (US)
- UPMC Hillman Cancer Center (US)
- Corresponding author
- Wherry, E. John
- ORCID
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2016-08
- Volume
- 45
- Issue
- 2
- Pages
- 358-373
- ISSN
- 1074-7613 (ISSN-L)
- PMC
- PMC4988919
- OpenAlex
- W2478467838
- Cited by
- 868
- References
- 40
- Citations by year
- 2026: 127 · 2025: 87 · 2024: 93 · 2023: 89 · 2022: 92 · 2021: 107 · 2020: 85 · 2019: 63 · 2018: 59 · 2017: 55 · 2016: 10
- FWCI
- 33.62
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Immunity (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (P50CA121973, P50CA097190)
- National Institute of Allergy and Infectious Diseases (R01AI115712, R01AI105343, P01AI112521, R21AI117718, U01AI095608, U19AI082630, P01AI108545)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- PD-1, CD8+ T cell exhaustion, glycolysis, mitochondrial metabolism, PGC-1α, mTOR signaling, glucose uptake, chronic viral infection, lymphocytic choriomeningitis virus, PD-L1 blockade, immune checkpoint blockade
- MeSH terms
- Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, Animals, Cells, Cultured, Energy Metabolism, Glucose, Lymphocytic Choriomeningitis, Lymphocytic choriomeningitis virus, Mice, Inbred C57BL, Signal Transduction, Cellular Senescence, Mice, Knockout, CD8-Positive T-Lymphocytes, Mice, Antibodies, Neutralizing, TOR Serine-Threonine Kinases, B7-H1 Antigen, Programmed Cell Death 1 Receptor, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review